Medtronic
UBS Raises Medtronic Target Price Amid Strong Q2, PFA Technology Shines, But "Neutral" Stance Lingers
New York, NY – November 20, 2025 – UBS Group has adjusted its outlook on Medtronic plc (NYSE: MDT) stock, raising its price target to $102.00 from $95.00. This upward revision follows Medtronic's stronger-than-expected second-quarter fiscal 2026 earnings report, which showcased robust performance driven by key segments and
